ESR1 and breast cancer: Our results show a higher upregulation of pS2 when comparing with AREG and PGR. In fact, it has been reported for the ER+ MCF-7 BC cell line that, upon estrogen exposure, pS2 expression strongly increases compared to PGR, at mRNA and also at protein levels [63, 64].